Signal transduction of eNOS activation

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 532-541

  Fleming, Ingrid ^a   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Endothelial function; Nitric oxide; Signal transduction

Indexed keywords

CALCIUM ION; CALMODULIN; CALMODULIN INHIBITOR; CAVEOLIN; HEAT SHOCK PROTEIN 90; MEMBRANE PHOSPHOLIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

BIOSYNTHESIS; CALCIUM CELL LEVEL; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; ENZYME RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; VASCULAR ENDOTHELIUM;

EID: 0033566864     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00094-2     Document Type: Review

References (98)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
2. Palmer R.M.J., Ferridge A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
3. Furchgott R.F. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activable inhibitory factor from bovine retractor penis is organic nitrite and the endothelium-derived relaxing factor is nitric oxide. Vanhoutte P.M. Mechanisms of vasodilation. 1988;401-418 Raven Press, New York.
4. Ignarro L.J., Byrns R., Buga G.M., Wood R.S., Chaudhuri G. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study the endothelium-dependent and nitric oxide elicited vascular smooth muscle relaxation. J. Pharmacol. Exp. Ther. 244:1987;181-189.
5. Chen P.F., Tsai A.L., Berka V., Wu K.K. Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behaviour of heme and other redox centers. J. Biol. Chem. 272:1997;6114-6118.
6. Sessa W.C., Harrison J.K., Barber C.M., et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 267:1992;15274-15276.
7. Ghosh D.K., Wu C.Q., Pitters E., et al. Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 48 amino acid sequence required for subunit dimerization and tetrahydrobiopterin interaction. Biochemistry. 36:1997;10609-10619.
8. Crane B.R., Arvai A.S., Ghosh D.K., et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science. 279:1998;2121-2126.
9. Raman C.S., Li H., Martásek P., et al. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell. 95:1998;939-950.
10. Presta A., Liu J., Sessa W.C., Stuehr D.J. Substrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activity. Nitric Oxide. 1:1997;74-87.
11. List B.M., Klosch B., Volker C., et al. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: Tetrahydrobiopterin binding kinetics and role of heme in dimerization. Biochem. J. 323:1997;159-165.
12. Chen P.-F., Tsai A.L., Wu K.K. Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers. J. Biol. Chem. 269:1994;25062-25066.
13. Martasek P., Liu Q., Liu J., et al. Characterization of bovine endothelial nitric oxide synthase expressed in E. coli. Biochem. Biophys. Res Commun. 219:1996;359-365.
14. Abu-Soud H.M., Gachhui R., Raushel F.M., Stuehr D.J. The ferrous-dioxy complex of neuronal nitric oxide synthase. Divergent effects of L-arginine and tetrahydropiopterin on its stability. J. Biol. Chem. 272:1997;17349-17353.
15. Abu-Soud H.M., Stuehr D.J. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad. Sci. USA. 90:1993;10769-10772.
16. Venema V.J., Ju H., Zou R., Ryan J.W., Venema R.C. Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J.Biol.Chem. 272:1997;1276-1282.
17. Siddhanta U., Presta A., Fan B.C., et al. Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer. J. Biol. Chem. 273:1998;18950-18958.
18. Pou S., Pou W.S., Bredt D.S., Snyder S.H., Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267:1992;24173-24176.
19. Cosentino F., Katusic Z.S. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 91:1995;139-144.
20. Wever R.M., Vandam T., Vanrijn H.J., Degroot F., Rabelink T.J. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem. Biophys. Res. Commun. 237:1997;340-344.
21. Vasquezvivar J., Kalyanaraman B., Martasek P., et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc. Natl. Acad. Sci. USA. 95:1998;9220-9225.
22. Xia Y., Tsai A.L., Berka V., Zweier J.L. Superoxide generation from endothleial nitric-oxide synthase. J. Biol. Chem. 273:1998;25804-25808.
23. Pritchard K.A., Groszek L., Smalley D.M., et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ. Res. 77:1995;510-518.
24. Cosentino F., Katusic Z.S. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 91:1995;139-144.
25. Stroes E., Kastelein J., Cosentino F., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest. 99:1998;41-46.
26. Busse R., Mülsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 265:1990;133-136.
27. Busse R., Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann. Med. 27:1995;331-340.
28. Singer A.H., Peach M.J. Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension. 4:1982;II-19-II-25.
29. Lückhoff A., Pohl U., Mülsch A., Busse R. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br. J. Pharmacol. 95:1988;189-196.
30. Nishida K., Harrison D.G., Navas J.P., et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90:1992;2092-2096.
31. Bredt D.S., Huang P.M., Glatt C.E., et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714-718.
32. Marsden P.A., Schappert K.T., Chen H.S., et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 307:1992;287-293.
33. Venema R.C., Sayegh H.S., Kent J.D., Harrison D.G. Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J. Biol. Chem. 271:1996;6435-6440.
34. Venema R.C., Sayegh H.S., Arnal J.-F., Harrison D.G. Role of enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase. J. Biol. Chem. 270:1995;14705-14711.
35. 2+-calmodulin. Biochemistry. 35:1996;14651-14658.
36. Gachhui R., Abu-Soud H.M., Ghoshà D.K., et al. Neuronal nitric oxide synthase interaction with calmodulin-troponin C chimeras. J. Biol. Chem. 273:1998;5451-5454.
37. Ghosh S., Gachhui R., Crooks C., et al. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J. Biol. Chem. 273:1998;22267-22271.
38. Salerno J.C., Harris D.E., Irizarry K., et al. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J. Biol. Chem. 272:1997;29769-29777.
39. Lisanti M.P., Scherer P.E., Tang Z., Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 4:1994;231-235.
40. Rothberg K.G., Heuser J.E., Donzell W.C., et al. Caveolin, a protein component of caveolae membrane coats. Cell. 68:1992;673-682.
41. Okamoto T., Schlegel A., Scherer P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes at the plasma membrane'. J. Biol. Chem. 273:1998;5419-5422.
42. Sessa W.C., García-Cardena G., Liu J., et al. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J. Biol. Chem. 270:1995;17641-17644.
43. O'Brien A.J., Young H.M., Povey J.M., Furness J.B. Nitric oxide synthase is localized predominantly in the Golgi apparatus and cytoplasmic vesicles of vascular endothelial cells. Histochemistry. 103:1995;221-225.
44. Liu J., Hughes T.E., Sessa W.C. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J. Cell. Biol. 137:1997;1525-1535.
45. Hecker M., Mülsch A., Bassenge E., Förstermann U., Busse R. Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: physiological implications. Biochem. J. 299:1994;247-252.
46. Shaul P.W., Smart E.J., Robinson L.J., et al. Acylation targets endothelial nitric oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271:1996;6518-6522.
47. Feron O., Belhassen L., Kobzik L., et al. Endothelial nitric oxide synthase targeting to caveolae: Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271:1996;22810-22814.
48. Liu J., García-Cardena G., Sessa W.C. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry. 35:1996;1.
49. García-Cardena G., Oh P., Liu J., Schnitzer J.E., Sessa W.C. Targeting of nitric oxide synthase to endothelial caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA. 93:1996;6448-6453.
50. Bauersachs J., Fleming I., Scholz D., Popp R., Busse R. Endothelium-derived hyperpolarizing factor but not nitric oxide is reversibly inhibited by brefeldin A. Hypertension. 30:1997;1598-1605.
51. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272:1997;6525-6533.
52. Michel J.B., Feron O., Sase K., Prabhakar P., Michel T. Caveolin versus calmodulin: Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J. Biol. Chem. 272:1997;25907-25912.
53. García-Cardena G., Martasek P., Masters B.S., et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: Functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem. 272:1997;25437-25440.
54. Ju H., Zou R., Venema V.J., Venema R.C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272:1997;18522-18525.
55. 2+-calmodulin and caveolin. J. Biol. Chem. 272:1997;15583-15586.
56. García-Cardena G., Fan G., Stern D.F., Liu J., Sessa W.C. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271:1996;27237-27240.
57. Fleming I., Fisslthaler B., Busse R. The endothelial NO synthase exists in situ as a protein complex the constituents of which are altered following endothelial cell stimulation with a tyrosine phosphatase inhibitor [abstract]. Nitric Oxide. 2:1998;91.
58. Venema V.J., Zou R., Ju H., Marrero M.B., Venema R.C. Caveolin-1 detergent solubility and association with endothelial nitric oxide synthase is modulated by tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 236:1997;155-161.
59. Fleming I., Bauersachs J., Fisslthaler B., Busse R. Calcium-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ. Res. 81:1998;686-695.
60. Robinson L.J., Busconi L., Michel T. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J. Biol. Chem. 270:1995;995-998.
61. Prabhakar P., Thatte H.S., Goetz R.M., et al. Receptor-regulated translocation of endothelial nitric oxide synthase. J. Biol. Chem. 273:1998;27383-27388.
62. Liu J., García-Cardena G., Sessa W.C. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry. 34:1995;12333-12340.
63. Venema V.J., Marrero M.B., Venema R.C. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem. Biophys. Res. Commun. 226:1996;703-710.
64. 2 receptor with endothelial nitric oxide synthase. J. Biol. Chem. 273:1998;24025-24029.
65. 2 kinin receptor within the plasma membrane of native endothelial cells. Circulation. 99:1999;2034-2040.
66. Andries L.J., Brutsaert D.L., Sys S.U. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ. Res. 82:1998;195-203.
67. Rajotte D., Arap W., Hagedorn M., et al. Molecular heterogeneity of the vascular endothelium revealed by in vitro phage display. J. Clin. Invest. 102:1998;430-437.
68. Fleming I., Hecker M., Busse R. Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ. Res. 74:1994;1220-1226.
69. Ayajiki K., Kindermann M., Hecker M., Fleming I., Busse R. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ. Res. 78:1996;750-758.
70. Griscavage J.M., Fukuto J.M., Komori Y., Ignarro L.J. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. J. Biol. Chem. 269:1994;21644-21649.
71. Sheehy A.M., Burson M.A., Black S.M. Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide. Am. J. Physiol. 247:1998;L833-L841.
72. Chao D.S., Gorospe J.R.M., Brenman J.E., et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J. Exp. Med. 184:1996;609-618.
73. Brenman J.E., Chao D.S., Gee S.H., et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell. 84:1996;757-767.
74. Jaffrey S.R., Snyder S.H. PIN: An associated protein inhibitor of neuronal nitric oxide synthase. Science. 274:1996;774-777.
75. Liang P., Macrae T.H. Molecular chaperones and the cytoskeleton. J. Cell Sci. 110:1997;1431-1440.
76. Pratt W.B. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptor signaling via MAP kinase. Annu. Rev. Pharmacol. Toxicol. 37:1997;297-326.
77. v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. USA. 91:1994;8324-8328.
78. vsrc1. Cancer Res. 49:1989;780-785.
79. García-Cardena G., Fan R., Shah V., et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 292:1998;821-824.
80. Mimnaugh E.G., Worland P.J., Whitesell L., Neckers L.M. Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp60v-src tyrosine kinase. J. Biol. Chem. 270:1995;28654-28659.
81. Gradin K., Whitelaw M.L., Toftgard R., Poellinger L., Berghard A. A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J. Biol. Chem. 269:1998;23800-23807.
82. Michel T., Li G.K., Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 90:1993;6252-6256.
83. Hirata K., Kuroda R., Sakoda T., et al. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension. 25:1995;180-185.
84. Corson M.A., James N.L., Latta S.E., et al. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res. 79:1996;984-991.
85. Tsukahara H., Gordienko D.V., Goligorsky M. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 193:1993;722-729.
86. Davada R.K., Chandler L.J., Guzman N.J. Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. Eur. J. Pharmacol. 266:1994;237-244.
87. Fleming I., Fisslthaler B., Busse R. Shear stress-induced phosphorylation of the endothelial NO synthase [abstract]. Nitric Oxide. 2:1998;76.
88. Zoche M., Beyermann M., Koch K.W. Introduction of a phosphate at serine(741) of the calmodulin-binding domain of the neuronal nitric oxide synthase (NOS-I) prevents binding of calmodulin. Biol. Chem. 378:1997;851-857.
89. Dimmeler S., Fisslthaler B., Fleming I., et al. Shear stress stimulates the protein kinase Akt-involvement in regulation of the endothelial nitric oxide synthase [abstract]. Circulation. 98:1998;I-312.
90. Fleming I., Fisslthaler B., Busse R. Interdependence of calcium signaling and protein tyrosine phosphorylation in human endothelial cells. J. Biol. Chem. 271:1996;11009-11015.
91. Fleming I., Busse R. Tyrosine phosphorylation and bradykinin-induced signaling in endothelial cells. Am. J. Cardiol. 80:1997;102A-109A.
92. Mülsch A., Bassenge E., Busse R. Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn Schmiedeberg's Arch. Pharmacol. 340:1989;767-770.
93. Kuchan M.J., Frangos J.A. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am. J. Physiol. 266:1994;C628-C636.
94. Hutcheson I.R., Griffith T.M. Mechanotransduction through the endothelial cytoskeleton: mediation of flow- but not agonist-induced EDRF release. Br. J. Pharmacol. 118:1996;720-726.
95. Muller J.M., Chilian W.M., Davis M.J. Integrin signaling transduces shear stress-dependent vasodilation of coronary arterioles. Circ. Res. 80:1997;320-326.
96. Fleming I., Bauersachs J., Busse R. Calcium-dependent and -independent activation of the endothelial NO synthase. J. Vasc. Res. 34:1997;165-174.
97. Ingber D.E. Tensegrity: The architectural basis of cellular mechanotransduction. Annu. Rev. Physiol. 59:1997;575-599.
98. Maniotis A.J., Chen C.S., Ingber D.E. Demonstration of mechanical connections between integrins cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. USA. 94:1997;849-854.